Influence of Immunogenicity on the Efficacy of Long-Term Treatment with TNF α Blockers in Rheumatoid Arthritis and Spondyloarthritis Patients

Figure 1

ADA (a), ETA (b), and INF (c) levels (μg/mL) in responders versus nonresponders RA and SpA patients (, , and , resp.). Data presented as interquartile ranges (75th centile, upper edge of the box; 25th centile, lower edge of the box, and 50th centile, midline of the box).

(a)

(b)

(c)